(Q80969122)
Statements
Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor (English)
John L Marshall
Hedy Kindler
John Deeken
Pankaj Bhargava
Nicholas J Vogelzang
Naiyer Rizvi
Taina Luhtala
Stacy Boylan
Margaret Dordal
Philmore Robertson
Michael J Hawkins
1 January 2005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference